Progenity (PROG) stock Forecast for 2022 – 2026
Last update: 05-16-2022, 11:09Sector: Healthcare
The share price of Progenity, Inc. (PROG) now
What analysts predict:: $4
52-week high/low: $6.2 / $0.657
50/200 Day Moving Average: $1.168 / $1.85
This figure corresponds to the average price over the previous 50/200 days. For Progenity stocks, the 50-day moving average is the resistance level today.
For Progenity stocks, the 200-day moving average is the resistance level today.
Are you interested in Progenity, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Progenity stock price in 2022, 2023, 2024, 2025, 2026. How much will one Progenity share be worth in 2022 - 2026?
When should I take profit in Progenity stock? When should I record a loss on Progenity stock? What are analysts' forecasts for Progenity stock? What is the future of Progenity stock?
We forecast Progenity stock performance using neural networks based on historical data on Progenity stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Progenity stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Progenity shares. This happens once a day.
Historical and forecast chart of Progenity stock
The chart below shows the historical price of Progenity stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Progenity stock price can be found in the table below.
Long-term forecasts by years.
Progenity daily forecast for a month
Progenity Daily Price Targets
Progenity Stock Forecast 05-18-2022.
Pessimistic target level: 0.82
Optimistic target level: 0.88
Progenity Stock Forecast 05-19-2022.
Pessimistic target level: 0.81
Optimistic target level: 0.88
Progenity Stock Forecast 05-20-2022.
Pessimistic target level: 0.76
Optimistic target level: 0.83
Progenity Stock Forecast 05-21-2022.
Pessimistic target level: 0.71
Optimistic target level: 0.78
Progenity Stock Forecast 05-22-2022.
Pessimistic target level: 0.72
Optimistic target level: 0.80
Progenity Stock Forecast 05-23-2022.
Pessimistic target level: 0.68
Optimistic target level: 0.75
PROG (PROG) Monthly Stock Prediction for 2022
Progenity forecast for this year
Progenity Stock Prediction for Jun 2022
An uptrend is forecast for this month with an optimal target price of $0.861149. Pessimistic: $0.75. Optimistic: $0.95
Progenity Stock Prediction for Jul 2022
An uptrend is forecast for this month with an optimal target price of $1.09418. Pessimistic: $0.90. Optimistic: $1.25
Progenity Stock Prediction for Aug 2022
An downtrend is forecast for this month with an optimal target price of $1.03279. Pessimistic: $0.95. Optimistic: $1.23
Progenity Stock Prediction for Sep 2022
An downtrend is forecast for this month with an optimal target price of $0.729462. Pessimistic: $0.57. Optimistic: $0.83
Progenity Stock Prediction for Oct 2022
An downtrend is forecast for this month with an optimal target price of $0.650023. Pessimistic: $0.50. Optimistic: $0.80
Progenity Stock Prediction for Nov 2022
An downtrend is forecast for this month with an optimal target price of $0.645733. Pessimistic: $0.48. Optimistic: $0.80
Progenity Stock Prediction for Dec 2022
An downtrend is forecast for this month with an optimal target price of $0.637209. Pessimistic: $0.53. Optimistic: $0.73
Progenity (PROG) Monthly Stock Prediction for 2023
Progenity (PROG) Monthly Stock Prediction for 2024
Progenity (PROG) Monthly Stock Prediction for 2025
Progenity (PROG) Monthly Stock Prediction for 2026
Progenity information and performance
Progenity, Inc. is a biotechnology company. The company develops and commercializes molecular testing and precision medicine products. It is applying a multi-ohmic approach combining genomics, epigenomics, proteomics and metabolomics to its molecular testing products and the development of a set of investigational swallowable devices and drug / device combinations designed for accurate diagnostic sampling and drug delivery. It offers integrated molecular tests and end-to-end testing. Supporting services that enable clinicians to create multiple tests from a single source. The Company’s molecular tests include: Congenital Prenatal Screening, Preparent Carrier Test, Riscover Hereditary Cancer Test, Resura Prenatal Test for Monogenic Disease, and Anatomical and Molecular Pathology Tests. The company also offers an oral platform for the diagnosis and treatment of gastrointestinal disorders.
4330 LA JOLLA VILLAGE DRIVE, SUITE 200, SAN DIEGO, CA, US
Market Capitalization: 162 924 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: - $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: None
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 3.104
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 161.13
Enterprise Value (EV) /Revenue
EV To EBITDA: -
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 184199000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.